Related references
Note: Only part of the references are listed.Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma
Richard A. Smith et al.
AMERICAN JOURNAL OF SURGERY (2009)
Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients - analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO
Rohini Sharma et al.
BMC CANCER (2009)
Intensive anti-inflammatory therapy with dexamethasone in patients with non-small cell lung cancer: effect on chemotherapy toxicity and efficacy
Markos Leggas et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Systemic inflammation, nutritional status and survival in patients with cancer
Donald C. McMillan
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2009)
C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer
Tomasz M. Beer et al.
CANCER (2008)
C-reactive protein and colorectal cancer risk: A systematic review of prospective studies
Konstantinos K. Tsilidis et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy
Shahrokh F. Shariat et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Inflammation and cancer: An ancient link with novel potentials
S. Perwez Hussain et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality - A European study of 313 patients
Pierre I. Karakiewicz et al.
CANCER (2007)
Inflammation-mediated cytosine damage: A mechanistic link between inflammation and the epigenetic alterations in human cancers
Victoria Valinluck et al.
CANCER RESEARCH (2007)
The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer
Takeharu Yamanaka et al.
ONCOLOGY (2007)
A systematic review of the association between circulating concentrations of C reactive protein and cancer
Katriina Heikkila et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2007)
Predicting the toxicity of weekly docetaxel in advanced cancer
Kellie A. Charles et al.
CLINICAL PHARMACOKINETICS (2006)
Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene
MG Borrello et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer
SR Walsh et al.
JOURNAL OF SURGICAL ONCOLOGY (2005)
The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder
M Hilmy et al.
BRITISH JOURNAL OF CANCER (2005)
Pretreatment with dexamethasone increases antitumor activity of carboplatin and gemcitabine in mice bearing human cancer xenografts:: In vivo activity, pharmacokinetics, and clinical implications for cancer chemotherapy
H Wang et al.
CLINICAL CANCER RESEARCH (2004)
Cytokines in pancreatic carcinoma - Correlation with phenotypic characteristics and prognosis
B Ebrahimi et al.
CANCER (2004)
Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer
LM Forrest et al.
BRITISH JOURNAL OF CANCER (2003)
Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease
P Munkholm
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Serum interleukin-6 levels reflect the disease status of colorectal cancer
YC Chung et al.
JOURNAL OF SURGICAL ONCOLOGY (2003)
Elevation of cytokine levels in cachectic patients with prostate carcinoma
J Pfitzenmaier et al.
CANCER (2003)
Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy
J Alexandre et al.
ANNALS OF ONCOLOGY (2003)
Hepatic cytochrome P450 3A drug metabolism is reduced in cancer patients who have an acute-phase response
LP Rivory et al.
BRITISH JOURNAL OF CANCER (2002)
The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer
HR Scott et al.
BRITISH JOURNAL OF CANCER (2002)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator
F De Vita et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2001)